Vascular Risk Factors and Dementia in the Oldest-Old
老年人的血管危险因素和痴呆症
基本信息
- 批准号:8458480
- 负责人:
- 金额:$ 29.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-15 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAgeAge of OnsetAge-YearsAged, 80 and overAgingAntihypertensive AgentsAutopsyBenefits and RisksBlood PressureBlood VesselsBrainCessation of lifeCholesterolClinicalCognitionCognitiveConflict (Psychology)CountryDataData AnalysesDatabasesDementiaDiastolic blood pressureDisease ManagementElderlyEpidemicHealthHypertensionIncidenceIndividualIntakeLifeLipidsMeasurementMeasuresMediatingMethodsParticipantPathologyPharmaceutical PreparationsPopulationPreventionPublic HealthRecommendationRecording of previous eventsReportingResearchRiskRisk FactorsSecondary toUnited StatesVascular DementiaVascular Diseasesage groupagedblood lipidbrain tissuecohorthealth practicehigh riskhypercholesterolemiahypertension treatmentmiddle agepopulation basedresponsevascular factor
项目摘要
DESCRIPTION (provided by applicant): Vascular risk factors (including hypertension and high cholesterol) during mid-life have been reported by many studies to increase the risk for dementia in later life. This has significant implications for dementia prevention as many vascular factors are modifiable. Most studies, however, have not explored these associations in the oldest-old (people 90 years and older) and it is not clear if the same vascular risk factors when present in very late-life are associated with increased risk of dementia and its related pathologies. In a preliminary study of oldest-old participants, we found a history of high blood pressure and history of high cholesterol to be less common in people who developed dementia compared to people who did not. Because at younger ages high blood pressure and high cholesterol are associated with increased dementia risk dementia, the relationship between these vascular factors and dementia appear to change with age. Thus, recommendations for treatment of vascular disease may be different for the very elderly as for younger people. We propose to study the association between vascular risk factors (namely hypertension and hypercholesterolemia) and risk of dementia in the oldest-old. A second objective is to generate new measures of microvascular pathologies in existing brains and investigate whether any association between vascular risk factors and dementia are mediated by vascular pathologies. Hypertension will be assessed in several different ways; by history collected when participants were on average 70 years of age, by history when participants were 90 years and older, and by direct blood pressure measurements at age 90 and older. Hypercholesterolemia will be similarly defined by history and direct lipid measurements obtained at age 90 and older. Intake of blood pressure and lipid lowering medications will be accounted for in the analyses of the associations. As this proposal is in response to an secondary data analysis announcement, most of the data to be analyzed has already been collected as part of The 90+ Study, one of the largest population-based studies of aging and dementia in people aged 90 years and older who have been extensively evaluated during life and a subset of them have agreed to undergo brain autopsy upon death. Vascular disease and dementia are both very common conditions in the oldest-old. As the oldest-old is the fastest growing segment of the population in the United States, dementia will become a public health epidemic in the coming decades. It is crucial to elucidate the association between potentially modifiable factors and dementia in this age group. If the associations between vascular risk factors and dementia change with age, the risks and benefits of treating vascular risk factors may also change with age. As much of current health practice relies on managing vascular disease, finding that reduced blood pressure and reduced cholesterol in the very elderly are not beneficial for cognitive health and its associated pathologies, and may even be harmful, disease management practices would need to be re-evaluated for the very elderly.
PUBLIC HEALTH RELEVANCE: Vascular disease and dementia are both very common conditions in the oldest-old. As the oldest-old is the fastest growing segment of the population in
the United States and many other countries, dementia threatens to become a public health epidemic in the coming decades. It is thus crucial to elucidate the association between potentially modifiable factors and dementia in this age group. As much of current health practice relies on managing vascular disease, finding that reduced blood pressure and reduced cholesterol in the very elderly are not beneficial for cognitive health and its associated pathologies, and may even be harmful, disease management practices would need to be re-evaluated for the very elderly.
描述(由申请人提供):许多研究报道了中年血管危险因素(包括高血压和高胆固醇)会增加晚年痴呆的风险。这对预防痴呆症具有重要意义,因为许多血管因素是可以改变的。然而,大多数研究并没有在老年人(90岁及以上的人)中探索这些关联,也不清楚同样的血管危险因素在非常晚年时是否与痴呆及其相关病理的风险增加有关。在一项针对最年长参与者的初步研究中,我们发现,与没有患痴呆症的人相比,患痴呆症的人有高血压和高胆固醇病史的情况更少。因为在年轻的时候,高血压和高胆固醇与痴呆症的风险增加有关,这些血管因素和痴呆症之间的关系似乎随着年龄的增长而改变。因此,对于老年人和年轻人的血管疾病治疗建议可能不同。我们建议研究血管危险因素(即高血压和高胆固醇血症)与老年人痴呆风险之间的关系。第二个目标是生成现有大脑微血管病变的新测量方法,并研究血管病变是否介导了血管危险因素与痴呆之间的任何关联。高血压将以几种不同的方式进行评估;通过参与者平均年龄为70岁时收集的历史,参与者90岁及以上时的历史,以及90岁及以上时直接测量的血压。高胆固醇血症同样可以通过90岁及以上的病史和直接脂质测量来定义。血压和降脂药物的摄入将在相关分析中考虑。由于这一提议是对二级数据分析公告的回应,大部分需要分析的数据已经作为90+研究的一部分收集,这是最大的基于90岁及以上人群的衰老和痴呆研究之一,这些人在生前得到了广泛的评估,其中一部分人已经同意在死亡时进行大脑解剖。血管疾病和痴呆都是老年人非常常见的疾病。由于老年人是美国人口中增长最快的部分,痴呆症将在未来几十年成为一种公共卫生流行病。阐明这一年龄组的潜在可改变因素与痴呆之间的关系至关重要。如果血管危险因素和痴呆之间的关联随着年龄的增长而变化,那么治疗血管危险因素的风险和益处也可能随着年龄的增长而变化。由于目前的许多健康实践依赖于管理血管疾病,发现老年人降低血压和降低胆固醇对认知健康及其相关病理没有好处,甚至可能有害,因此需要重新评估老年人的疾病管理实践。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria Corrada其他文献
Maria Corrada的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria Corrada', 18)}}的其他基金
Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old
多种族老年人群体中年龄相关性痴呆、轻度认知障碍和脑病理学的流行病学
- 批准号:
9828946 - 财政年份:2017
- 资助金额:
$ 29.47万 - 项目类别:
Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old
多种族老年人群体中年龄相关性痴呆、轻度认知障碍和脑病理学的流行病学
- 批准号:
10654739 - 财政年份:2017
- 资助金额:
$ 29.47万 - 项目类别:
Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old - Administrative Supplement
多种族老年人群体中年龄相关性痴呆、轻度认知障碍和脑病理学的流行病学 - 行政补充
- 批准号:
10075066 - 财政年份:2017
- 资助金额:
$ 29.47万 - 项目类别:
Vascular Risk Factors and Dementia in the Oldest-Old
老年人的血管危险因素和痴呆症
- 批准号:
8545664 - 财政年份:2012
- 资助金额:
$ 29.47万 - 项目类别:
Vascular Risk Factors and Dementia in the Oldest-Old
老年人的血管危险因素和痴呆症
- 批准号:
8731172 - 财政年份:2012
- 资助金额:
$ 29.47万 - 项目类别:
Vascular Risk Factors and Dementia in the Oldest-Old
老年人的血管危险因素和痴呆症
- 批准号:
8681259 - 财政年份:2012
- 资助金额:
$ 29.47万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 29.47万 - 项目类别:
Research Grant